Dr. Reddy's Announces the Launch of Three Generic Drugs in the US
Submitted by Kanika Mehta on Tue, 06/07/2011 - 11:37
Indian pharmaceutical company, Dr. Reddy's Laboratories today announced the launch of three drugs in the US market. The two drugs are approved by the US drug regulator and are designed to treat central nervous system disorders.
Dr Reddy’s net profit up by 32%
Submitted by Faarooq Mehmood on Sun, 10/24/2010 - 11:18
Leading Pharmaceutical firm of the country Dr Reddy's Laboratories Ltd has announced its second quarter financial results. The company has informed that the net profit of the company has gone up by 32% in the quarter under review.
Dr.Reddy’s Laboratories get US FDA OK for Generic Tacrolimus
Submitted by Maninder Singh on Fri, 05/14/2010 - 16:38
A spokesperson for the Indian drug maker said Friday, From the U. S Food and Drug Administration, Dr. Reddy’s Laboratories has received approval, to sell generic immune system drug tacrolimus for organ transplants recipients.
